NOVEL FORMS OF MU-OPIOID RECEPTOR AGONIST

The present invention discloses novel polymorphs of 5-[[[(2S)-2-amino-3-[4- (aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H- imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid and its pharmaceutically acceptable salts. L'invention concerne de nouveaux polymorphes d...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MALHOTRA, Geena, RAO, Dharmaraj Ramachandra, TARATE, Sagar Narayan, THOPPIL, Sanoj Jose, CHAUGULE, Hanmant Nagnath, PHULL, Manjinder Singh
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention discloses novel polymorphs of 5-[[[(2S)-2-amino-3-[4- (aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-(4-phenyl-1H- imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid and its pharmaceutically acceptable salts. L'invention concerne de nouveaux polymorphes d'acide 5-[[[(2S)-2-amino-3-[4-(aminocarbonyl)-2,6-diméthylphényl]-1-oxopropyl][(1S)-1-(4-phényl-1-H-imidazol-2-yl)éthyl]amino]méthyl]-2-méthoxybenzoïque, et ses sels pharmaceutiquement acceptables.